Tag Archives: NASDAQ:SESN

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sesen Bio (NASDAQ: SESN) and Amphastar Pharmaceuticals (NASDAQ: AMPH)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sesen Bio (SESN – Research Report) and Amphastar Pharmaceuticals (AMPH – Research Report). Sesen Bio (SESN) Canaccord Genuity analyst John Newman maintained a

Analysts Are Bullish on Top Healthcare Stocks: Sesen Bio (SESN), Arena Pharma (ARNA)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sesen Bio (SESN – Research Report) and Arena Pharma (ARNA – Research Report) with bullish sentiments. Sesen Bio (SESN) Canaccord Genuity analyst

Canaccord Genuity Reaffirms Their Buy Rating on Sesen Bio (SESN)

Canaccord Genuity analyst John Newman maintained a Buy rating on Sesen Bio (SESN – Research Report) yesterday and set a price target of $5.00. The company’s shares closed last Monday at $1.12. According to TipRanks.com, Newman is a 5-star analyst

Canaccord Genuity Keeps a Buy Rating on Sesen Bio (SESN)

In a report released today, John Newman from Canaccord Genuity maintained a Buy rating on Sesen Bio (SESN – Research Report), with a price target of $5.00. The company’s shares closed last Tuesday at $1.29. According to TipRanks.com, Newman is

Sesen Bio (SESN) Gets a Buy Rating from Canaccord Genuity

In a report released yesterday, John Newman from Canaccord Genuity maintained a Buy rating on Sesen Bio (SESN – Research Report), with a price target of $5.00. The company’s shares closed last Monday at $1.06. According to TipRanks.com, Newman is

Canaccord Genuity Thinks Sesen Bio’s Stock is Going to Recover

Canaccord Genuity analyst John Newman maintained a Buy rating on Sesen Bio (SESN – Research Report) yesterday and set a price target of $5.00. The company’s shares closed last Tuesday at $0.69, close to its 52-week low of $0.37. According